发布时间: 2026 - 07 - 04
Young investors are not just hunting for the next unicorn—they are incubating the future of a technologically powerful nation.Today, [Entrepreneur] officially unveiled its 2026 Young Venture Capital List. Zhu Pai, CEO of Efung Capital, has been named to the "Under 40 Investors" ranking, solidifying his position as a key driving force in the current wave of young venture capital.Entrepreneur has long focused on the young venture capital community. Since 2013, it has held the "Under 40 Investors" selection for 14 consecutive years, aiming to identify capital visionaries who a...
浏览次数:4
发布时间: 2026 - 07 - 01
On July 1, the NMPA official website announced that Omecamson (Agluconate Sodium Injection), a Class 1 new drug jointly filed by Omer Pharmaceutical and Xianju Pharmaceutical, has been approved for marketing in China.Notably, this drug is the only targeted muscle relaxant antagonist in China and one of only two worldwide. Upon approval, it has also become the only patent-protected drug in the muscle relaxant antagonism field globally.Screenshot from NMPA official websiteOmecamson:Making "Awakening" Safer and More ControllableMuscle relaxation is one of the three essential elements of...
浏览次数:7
发布时间: 2026 - 07 - 01
A century-long journey burns bright with our original aspiration as a guiding torch. As we celebrate the 105th anniversary of the founding of the Communist Party of China (CPC), the Party Branch of Shenzhen Efung Investment Management Enterprise (Limited Partnership) under the CPC organized a special study session for all Party members themed Revisit Red Memories, Consolidate the Foundation of Faith. Drawing spiritual strength by looking back on history and pooling consensus for hard work through ideological exchanges, we live up to the great founding spirit of the CPC with concrete actions.10...
浏览次数:3
发布时间: 2026 - 06 - 30
On June 10, 2026, the "Shenzhen Yifeng Mingyuan Seed Venture Investment Partnership (Limited Partnership)," established with equity participation from the Shenzhen Science and Technology Innovation Seed Fund, officially completed its business registration. This marks a critical step forward in Yifeng Capital's strategic deployment in ultra-early-stage investments.Notably, this month has brought a steady stream of positive developments across Yifeng Capital's portfolio ecosystem, with multiple investee companies achieving breakthrough progress in financing rounds and core busi...
浏览次数:5
103页次2/26首页PREV12345678910...NEXTlast page
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务